Mr. Schinecker, currently serving as Roche’s head of centralized and point-of-care solutions, will succeed Michael Heurer, who is retiring at the end of July.
Mr. Heurer had been serving as interim CEO of the $13 billion diagnostics unit, which includes diabetes care and personalized cancer treatments.
Roche also announced that Peter Voser will leave Roche’s board of directors by July.
More articles on pharmacy:
Sanofi poaches exec from Novartis
Eli Lilly’s migraine drug 1st approved to reduce cluster headaches: 4 notes
EpiPen shortage will drag on: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
